Predictions
Carl Zeiss Meditec AG
Start price
Target price
Perf. (%)
€87.10
05.05.19
05.05.19
€200.00
04.11.21
04.11.21
113.03%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Formycon AG
Start price
Target price
Perf. (%)
€35.10
27.04.19
27.04.19
€53.50
04.11.21
04.11.21
44.73%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Carl Zeiss Meditec AG
Start price
Target price
Perf. (%)
€67.50
27.07.18
27.07.18
€110.00
04.11.21
04.11.21
174.89%
05.11.21
05.11.21
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€34.41
09.11.20
09.11.20
€40.00
09.11.21
09.11.21
18.27%
02.11.21
02.11.21
Could be very worthwhile Investment >20% year
Market Leader or Top 3
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Nanorepro AG
Start price
Target price
Perf. (%)
€8.95
16.02.21
16.02.21
€5.00
16.02.22
16.02.22
-7.49%
18.10.21
18.10.21
Below average Management
Little innovation
Few uniques
Dependend from some customers or products
Formycon AG
Start price
Target price
Perf. (%)
€60.40
18.01.21
18.01.21
€80.00
18.01.22
18.01.22
-9.93%
04.10.21
04.10.21
Could be worthwhile Investment >10% per year
Bio-Gate AG
Start price
Target price
Perf. (%)
€4.40
26.09.21
26.09.21
-
26.09.22
26.09.22
-6.82%
03.10.21
03.10.21
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Heidelberg Pharma AG
Start price
Target price
Perf. (%)
€5.64
27.01.21
27.01.21
€8.00
27.01.22
27.01.22
9.75%
28.09.21
28.09.21
Could be worthwhile Investment >10% per year
Sartorius AG VZO
Start price
Target price
Perf. (%)
€413.70
18.06.21
18.06.21
€600.00
18.06.22
18.06.22
35.75%
27.09.21
27.09.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Good rating
High valuation
Nanorepro AG
Start price
Target price
Perf. (%)
€8.60
15.02.21
15.02.21
€20.00
15.02.22
15.02.22
5.47%
23.09.21
23.09.21
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Merck KGaA
Start price
Target price
Perf. (%)
€144.55
11.01.21
11.01.21
€145.00
11.01.22
11.01.22
42.10%
12.09.21
12.09.21
Could be very worthwhile Investment >20% year
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€39.22
04.01.21
04.01.21
€75.00
04.01.22
04.01.22
11.33%
05.09.21
05.09.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
MorphoSys AG
Start price
Target price
Perf. (%)
€47.81
30.08.21
30.08.21
€53.00
30.08.22
30.08.22
5.67%
04.09.21
04.09.21
Could be worthwhile Investment >10% per year
Innovative
Top 10 in its market
Higher risks for its business
Nanorepro AG
Start price
Target price
Perf. (%)
€16.00
12.03.21
12.03.21
€22.00
12.03.22
12.03.22
-62.19%
12.08.21
12.08.21
Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Higher risks for its business
Bio-Gate AG
Start price
Target price
Perf. (%)
€2.30
17.06.20
17.06.20
€5.00
04.11.21
04.11.21
73.91%
12.08.21
12.08.21
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Higher risks for its business
High valuation
Stratec SE
Start price
Target price
Perf. (%)
€121.80
20.07.21
20.07.21
€135.00
20.07.22
20.07.22
4.76%
30.07.21
30.07.21
Risky Investment